The first patient was a 50 years woman with acute myeloidleukemia.
2
Three cases of acute myeloidleukemia were reported in the HEC arm.
3
Seven patients were studied following bone marrow transplantation for chronic myeloidleukemia.
4
Acute myeloidleukemia and myelodysplastic syndromes represented the most common disease indications.
5
They include oncology drugs for melanoma, prostate cancer and acute myeloidleukemia.
Uso de myeloid leukaemia en inglés
1
Photo taken in 2019, just before she was diagnosed with acute myeloidleukaemia.
2
Background: There are little data from India on the management of acute myeloidleukaemia.
3
An autopsy later found the girl had acute myeloidleukaemia.
4
We report a cytogenetic subgroup of acute myeloidleukaemia whose incidence is independent of age.
5
His focus then turned towards developing novel therapeutics for paediatric and adult acute myeloidleukaemia.
6
Background: Safe and effective treatments are urgently needed for patients with relapsed or refractory acute myeloidleukaemia.
7
I had acute myeloidleukaemia and it was very close indeed, they caught it just in time.
8
Optometry student Vithiya Alphons was diagnosed with acute myeloidleukaemia in 2015 and needed a stem cell transplant.
9
Results: Patients with acute myeloidleukaemia submitted to induction treatment were the most susceptible to acquisition of fungal infections.
10
The disease progressed rapidly and transformed into therapy-related acute myeloidleukaemia in less than four months, complicated with severe pneumonia.
11
We aimed to assess the highly selective oral FLT3 inhibitor gilteritinib in patients with relapsed or refractory acute myeloidleukaemia.
12
The company said the Food and Drug Administration will review additional long-term data on Tasigna from patients with chronic myeloidleukaemia.
13
Because of the aggressive course of the disease the patient was treated with an acute myeloidleukaemia chemotherapy regimen without success.
14
We show, using chronic myeloidleukaemia as a model, that defining cancer latency is not as simple as it once seemed.
15
Background: Patients with myelodysplastic syndrome or acute myeloidleukaemia who are thrombocytopenic and unable to receive disease-modifying therapy have few treatment options.
16
A group of 510 patients affected by chronic myeloidleukaemia from 1977 to 1998 has been considered.